Skip to main content
SpringerLink
Log in
Book cover

Cancer du sujet âgé pp 117–131Cite as

Tumeurs gynécologiques

  • Chapter

  • 242 Accesses

Part of the book series: Oncologie pratique ((ONCOLPRAT))

Abstrait

Le cancer de l’ovaire touche souvent la femme âgée: il atteint la femme de moins de 45 ans dans environ 15 % des cas, de 45 à 65 ans dans 40 % des cas et après 65 ans dans 45 % des cas (8). Le nombre de nouveaux cas de cancer de l’ovaire est estimé pour la France, en 2000, à 4 488, représentant ainsi 3,8 % des cancers féminins. Le cancer de l’ovaire est responsable de 3 508 décès pour cette même année, soit un peu plus de 6 % des décès féminins par cancer (34). La probabilité pour une femme française d’avoir un cancer de l’ovaire au cours de sa vie est évaluée à 1,3 %. Les taux d’incidence spécifiques augmentent avec l’âge jusqu’à 65 ans pour l’incidence et d’une façon constante jusqu’aux âges les plus avancés pour la mortalité. Le cancer de l’ovaire est un cancer dont l’incidence serait en diminution depuis 1980, passant d’un taux d’incidence de 11,9 pour 100 000 femmes en 1980, à 9 en 2000 (34). Le taux de mortalité standardisé est de 5,4. Le cancer de l’ovaire partage certains facteurs de risque avec le cancer du sein, excepté la contraception orale qui aurait un effet protecteur dans la survenue d’un cancer ovarien.

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Anderson M, Storm H, Mouridsen H (1991) Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer. J Natl Cancer Inst 83: 1013–17

    Article  Google Scholar 

  2. Annual Report. Petterson F, Creasman WT, Shephard JH, Pecorelli S (1995) International Federation of Gynecology and Oncology, eds. Annual report on the results of treatment in gynecological cancer. Stockholm, Sweden: Editorial Office, Radiumhemmet

    Google Scholar 

  3. Baldwin JG (1988) Hematopoietic function in the elderly. Arch Intern Med 148: 2544–6

    Article  PubMed  Google Scholar 

  4. Brinton LA, Hamman RF, Huggins GR et al. (1987) Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J Natl Cancer Inst 79: 23–30

    PubMed  CAS  Google Scholar 

  5. Burke TW, Eiffel PJ, Muggia FM (1997) Cancer of the uterine body. In: Vita VT, Hellman S, Rosenberg SA. Cancer principles and practice of oncology. Philadelphia. Lippincott, Raven: 1478–502

    Google Scholar 

  6. Calais G, Vitu L, Descamps P et al. (1990) Preoperative or postoperative brachytherapy for patients with endometrial carcinoma stage I and II. Int J Radiat Oncol Biol Phys 19: 523.

    PubMed  CAS  Google Scholar 

  7. Edmonson JH, Su J, Crook JE (1993) Treatment of ovarian cancer in elderly women. Cancer 71: 615–17

    Article  PubMed  CAS  Google Scholar 

  8. Feuilhade F (1996) Le cancer de l’ovaire de la femme âgée. Cahier d’oncologie 5: 8–15

    Google Scholar 

  9. Fisher B, Costantino J, Redmond C, Fisher E, Wickerham L, Cronin W (1994) Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 86: 527–37

    Article  PubMed  CAS  Google Scholar 

  10. Fornander T, Rutqvist L, Cedermark B et al. (1989) Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1: 117–20

    Article  PubMed  CAS  Google Scholar 

  11. Freyer G, Weber B, Mousseau M et al. (2000) Multidimensional geriatric assessment (MGA) predicts feasibility of standart carboplatin (CB)-Cyclophospha-mide (CY) in women over 70 with advanced ovarian carcinoma (AOC): A GYNECO study. Proceedings of ASCO

    Google Scholar 

  12. Gerbaulet A, Horiot JC (1992) Généralités sur les traitements des cancers gynécologiques. In: Bourgeois JP, Chavaudra J, Eschwege F. Radiothérape oncologique, Paris, Hermann 270–80

    Google Scholar 

  13. Giovanazzi-Bannon S, Rademaker A, Lai G, Benson AB (1994) Treatment tolerance of elderly cancer patients entered into phase II clinical trials: an Illinois Cancer Center Study. J Clin Oncol 12: 2447–52

    PubMed  CAS  Google Scholar 

  14. Gloeckler Ries LA (1993) Ovarian cancer: survival and treatment differences by age. Cancer 71: 524–9

    Google Scholar 

  15. Grady D, Gebretsadik T, Kerlikowske K et al. (1995) Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 85: 304–13

    Article  PubMed  CAS  Google Scholar 

  16. Higginson J, Muir CS, Munoz N (1992) Human cancer: epidemiology and environnemental causes. Cambridge University Press. Cambridge 1–577

    Google Scholar 

  17. Hill C, Doyon F, Sancho-Garnier H (1997) Fr pidémiologie des cancers. Flammarion Paris: 53–6

    Google Scholar 

  18. Kalandidi A, Tzonou A, Lipworth L et al. (1996) A case-control study of endometrial cancer in relation to reproductive, somatometric and life-style variables. Oncology 53: 354–9

    Article  PubMed  CAS  Google Scholar 

  19. Kirova Y, Calitchi E, Feuilhade F (2001) Les cancers de l’ovaire et l’uterus chez la femme âgée. Oncologie 3: 94–9

    Google Scholar 

  20. Kolysko-Tuxen M, Lund B, Paaske O et al. (1993) Second look laparotomy in the management of patients after radical surgery for ovarian cancer. Ann Oncol 3: 169–71

    Google Scholar 

  21. La Vecchia C, Decarli A, Fasoli M, Gentile A (1986) Nutrition and diet in the etiology of endometrial cancer. Cancer 57: 1248–53

    Article  PubMed  Google Scholar 

  22. La Vecchia C, Franceschi S, Decarli A et al. (1984) Risk factors for endometrial cancer at different ages. J Natl Cancer Inst 73: 667–71

    PubMed  Google Scholar 

  23. Levi F, La Vecchia C, Negri E et al. (1992) Body mass at different ages and subsequent andometial cancer risk. Int J Cancer 50: 567–71

    Article  PubMed  CAS  Google Scholar 

  24. Markman M, Lewis JL, Saigo P et al. (1993) Epithelial ovarian cancer in the elderly: Memorial Sloan Kettering Cancer Center experience. Cancer 71: 634–7

    Article  PubMed  CAS  Google Scholar 

  25. Moradi T, Nyren O, Bergstrom R et al. (1998) Risk for endometrial cancer in relation to accupational physical ativity: a nationwide cohort study in Sweden. Int J Cancer 76: 665–70

    Article  PubMed  CAS  Google Scholar 

  26. NIH Consensus Statement (1994) Ovarian Cancer: screening, treatment and follow-up. 12: 1–30

    Google Scholar 

  27. Onetto N, Canetta R, Winograd B et al. (1993) Overview of taxol safety. A workshop on taxol and taxus. Monographs of the National Cancer Institute 15: 131–40

    Google Scholar 

  28. Orth G, Croissant O (1988) Papillomavirus humans et cancer. Bull Inst Pasteur 86: 297–315

    Google Scholar 

  29. Parazzini F, La Vecchia C, Bocciolone L, Franceschi S (1991) The epidemiology of endometrial cancer. Gynecol Oncol 41: 1–16

    Article  PubMed  CAS  Google Scholar 

  30. Potiscman N, Swanson CA, Brinton LA et al. (1993) Dietary associations in a case-control study of endometrial cancer. Cancer Causes Control 4: 239–50

    Google Scholar 

  31. Raverdy N (2000) Le cancer de l’ovaire. Incidence du cancer en France. Estimations régionales 1985–1995; pp 28

    Google Scholar 

  32. Ribeiro G, Swindell R (1992) The Christie Hospital adjuvant tamoxifen trial. NCI Monogr 11: 121–5

    Google Scholar 

  33. Rose PG0 (1996) Endometrial carcinoma. N Engl J Med 335: 640–49

    Article  PubMed  CAS  Google Scholar 

  34. Remontet L, Buemi A, Velten M et al. Evolution de l’incidence et de la mortalité par cancer en France de 1978 à 2000. Edition de l’Institut de veille sanitaire

    Google Scholar 

  35. Stewart H (1992) The Scottish trial of adjuvant tamoxifen in node-negative breast cancer: Scottish Cancer Trials Breast Group. NCI Monogr 11: 117–20

    Google Scholar 

  36. Thyss A, Saudes L, Otto J et al. (1994) Renal tolerance of cisplatine in patients more than 80 years old. J Clin Oncol 12: 2121–5

    PubMed  CAS  Google Scholar 

  37. Ursin G, Peters RK, Henderson BE et al. (1994) Oral contraceptive use and adenocarcinoma of cervix. Lancet 344: 1390–94

    Article  PubMed  CAS  Google Scholar 

  38. Van der Burg MEL, Van Lent M, Buise M et al. (1995) The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. N Engl J Med 332: 629–34

    Article  PubMed  Google Scholar 

  39. Zaheer W, Lichtman SM, De Marco L et al. (1994) The use of taxol in elderly patients. Proceedings of ASCO 13: 1518

    Google Scholar 

  40. Vasey PA, Jayson GC, Gordon A et al. (2004) Phase III Randomized trial of Docetaxel-Carboplatin vs Paclitaxel-Carboplatin as first line chemotherapy for ovarian carcinoma. J Natl Cancer Inst 96: 1682–91

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de radiothérapie, Institut Curie, 26, rue d’Ulm, 75005, Paris

    Youlia Kirova

  2. Service d’oncologie-radiothérapie, CHU Henri-Mondor, 51, avenue de Lattre-de-Tassigny, 94010, Créteil

    Elie Calitchi & Franck Feuilhade

Authors
  1. Youlia Kirova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elie Calitchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Franck Feuilhade
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Service d’oncologie médicale, CHU Avicenne, 125, rue de Stalingrad, 93009, Bobigny Cedex

    Jean-François Morère

  2. Centre de gériatrie, Hôpital Xavier-Arnozan, Avenue du Haut-Levêque, 33604, Pessac

    Muriel Rainfray

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag France

About this chapter

Cite this chapter

Kirova, Y., Calitchi, E., Feuilhade, F. (2007). Tumeurs gynécologiques. In: Morère, JF., Rainfray, M. (eds) Cancer du sujet âgé. Oncologie pratique. Springer, Paris. https://doi.org/10.1007/978-2-287-48618-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-48618-0_9

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-25209-9

  • Online ISBN: 978-2-287-48618-0

Publish with us

Policies and ethics

Search

Navigation